In a recent article for Healthcare Business Today, Avalon CEO Bill Kerr, MD, highlights how lab benefits management (LBM) is redefining the way health plans, providers, and members achieve better outcomes. With U.S. healthcare spending more than $90 billion on lab testing in 2024, Dr. Kerr emphasizes the importance of ensuring that the right tests are performed at the right time. By applying evidence-based guidelines, reducing unnecessary testing, and guiding providers toward high-quality, cost-effective labs, LBM not only improves care but also supports the broader shift to value-based healthcare.
Dr. Kerr also points to the critical role of data-driven insights in transforming lab testing into a powerful tool for advancing equity and precision medicine. As diagnostic science evolves rapidly, LBM helps health plans stay current while improving access to essential testing and strengthening provider relationships. To explore Dr. Kerr’s perspective on how Avalon is leading this transformation, read the full article in Healthcare Business Today.
